BioAlliance to cash $20 million milestone after miconazole's FDA approval
This article was originally published in Scrip
Executive Summary
BioAlliance Pharma is to receive a $20 million milestone payment from its US partner Strativa Pharmaceuticals after its antifungal miconazole Lauriad was approved by the US FDA for the treatment of oropharyngeal candidiasis (OPC) in adults.